Use of eculizumab in atypical hemolytic uremic syndrome associated with impaired renal function: integrative review. Arch. Health. Sci [Internet]. 2022 Dec. 16 [cited 2024 Nov. 22];26(1):72-5. Available from: https://ahs.famerp.br/index.php/ahs/article/view/101